Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01362140. IPD Sharing: Not stated. Countries: 9. Publications: 1.
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patient
ClinicalTrials.gov study NCT02775903. IPD Sharing: Not stated. Countries: 12. Publications: 4.
Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04160052. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003790. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00844441. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An European Platform for Translational Research in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04174547. IPD Sharing: NO. Countries: 4. Publications: 33.
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02319369. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00854646. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02942290. IPD Sharing: NO. Countries: 7. Publications: 1.
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00035867. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
ClinicalTrials.gov study NCT00906334. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
ClinicalTrials.gov study NCT04602273. IPD Sharing: UNDECIDED. Countries: 1. Publications: 17.
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05732103. IPD Sharing: NO. Countries: 1. Publications: 1.
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03383575. IPD Sharing: Not stated. Countries: 1. Publications: 1.
7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00301938. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations
ClinicalTrials.gov study NCT04493138. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01673308. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
ClinicalTrials.gov study NCT00687323. IPD Sharing: YES. Countries: 0. Publications: 1.
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
ClinicalTrials.gov study NCT01250951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.